Decoding Phytochemical Synergy: Systems-Based Mechanistic and In Vivo Evaluation of a Polyherbal Anti-Inflammatory and Analgesic Formulation

Polyherbal formulations are increasingly recognized for their multi-target therapeutic potential in managing complex conditions such as inflammation and pain; however, the mechanistic basis of phytochemical synergy remains inadequately understood. The present study was designed to evaluate a rationally developed polyherbal anti-inflammatory and analgesic formulation using a systems-based mechanistic approach integrated with in vivo validation. Phytochemical profiling and network pharmacology analysis were employed to identify key bioactive constituents and predict their molecular targets and pathways. The formulation was subsequently evaluated using established in vivo models, including carrageenan-induced paw edema for anti-inflammatory activity and standard nociceptive models for analgesic assessment. The results demonstrated a significant (p < 0.05) reduction in inflammatory response and pain perception compared to control groups, indicating potent pharmacological activity. Systems-level analysis revealed that major phytoconstituents, including flavonoids, phenolic acids, and terpenoids, collectively modulate multiple pro-inflammatory mediators such as cyclooxygenase-2 (COX-2), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6), suggesting a synergistic multi-target mechanism of action. The convergence of in vivo findings with network-based predictions highlights the role of phytochemical interactions in enhancing therapeutic efficacy. Overall, this study provides robust mechanistic and experimental evidence supporting the synergistic pharmacological potential of the developed polyherbal formulation and underscores the utility of integrating systems pharmacology with conventional in vivo approaches for the scientific validation and optimization of polyherbal therapeutics.